Information Provided By: 
Fly News Breaks for October 18, 2019
CSII
Oct 18, 2019 | 08:27 EDT
As previously reported, Guggenheim analyst Chris Pasquale initiated coverage of Cardiovascular Systems with a Buy rating and $58 price target. The company's OAS products have become the "tools of choice" for many physicians treating heavily calcified lesions, management has plans to diversify its portfolio, and the company has a ramping outside of the U.S. expansion effort underway, but he believes the Street "underestimates this potential inflection," said Pasquale, who expects sentiment to improve as visibility improves.
News For CSII From the Last 2 Days
There are no results for your query CSII
